New Jersey Leads the Nation in Opposing USPSTF PSA Testing Recommendation
Governor Chris Christie Signs Resolution Passed Unanimously by Legislature
January 17, 2012 /PRNewswire via COMTEX/ -- New Jersey Governor Chris Christie today signed legislation promoted by the New Jersey Patient Care and Access Coalition (NJPCAC) opposing an October 2011 U.S. Preventive Services Task Force (USPSTF) draft recommendation that healthy men should no longer receive prostate-specific antigen (PSA) blood tests as part of routine cancer screening. The legislative resolution was passed unanimously by both houses of the New Jersey Legislature on January 9th.
"New Jersey demonstrated remarkable leadership by taking swift and decisive action to oppose this dangerous recommendation," said Dr. David Taylor, Chairman of the Board of NJPCAC and President of Garden State Urology in Morristown. "Our entire Coalition joins me in congratulating the Governor and those in the Legislature who worked so hard to make this happen. Hopefully, this will send a loud and clear message to Washington that this flawed recommendation should not stand."
Dr. Taylor took note that the resolution was sponsored by New Jersey Assembly Republican Leader Alex DeCroce, who passed away the same evening as its passage. "Alex left an immense and lasting legacy in so many areas affecting all of us in New Jersey," he said. "It is truly fitting that one of his last actions could very well save lives. There is no more important element to saving the lives of men who develop prostate cancer than early detection."
The resolution (AJR89/SJR77), "memorializing the Congress of the United States to seek the withdrawal of the United States Preventive Services Task Force recommendation against prostate-specific antigen-based screening for prostate cancer for men in all age groups," was sponsored by Assembly members DeCroce and Joan Quigley and Senators Loretta Weinberg, Joseph Vitale and Fred Madden. It was passed by a vote of 74-0 in the Assembly and 36-0 in the Senate.
NJPCAC believes the USPSTF draft recommendation jeopardizes the health of countless Americans and needlessly puts in harm's way the men who are most at risk: those who are underinsured, live in areas where health care is not readily available, have a family history of prostate cancer, and particularly African-Americans (who have the highest incidence of and death rates from prostate cancer). NJPCAC supports the use of PSA screening and encourages men to have a discussion with their own physicians about whether to be screened for prostate cancer.
The full text of the resolution can be found here: http://www.njleg.state.nj.us/2010/Bills/AJR/89_I1.PDF
The New Jersey Patient Care and Access Coalition (NJPCAC) was organized to promote and represent the common interests of urological care physicians in the State of New Jersey who are dedicated to the highest standards of practice and focused on addressing the challenges that confront our healthcare system. NJPCAC 's membership includes nearly 200 practicing urologists and scores of additional healthcare professionals, including radiation oncologists, pathologists, and nurses , who have come together to educate policy makers, regulators, insurers and other key stakeholders, including patients and peers about legislative and regulatory changes that could impact the quality and accessibility to care provided to patients in New Jersey. Visit www.njpcac.org for more information about NJPCAC.
FOR MORE INFORMATION Donald Sico email@example.com 856-314-8066
SOURCE New Jersey Patient Care and Access Coalition
Copyright (C) 2012 PR Newswire. All rights reserved